• Search

Search in Site

PharmaDeviceNews | Pharma and Medical Device Industry News PharmaDeviceNews.com
  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»cancer theranostics

AI meets nuclear medicine as Sanyou Bio and Baiyunshan Xihe pursue cancer diagnostics

By Pallavi Madhiraju on July 6, 2026   Medical Devices & Diagnostics  

AI meets nuclear medicine as Sanyou Bio and Baiyunshan Xihe pursue cancer diagnostics

Explore how Sanyou Bio and Baiyunshan Xihe are combining AI discovery and nuclear medicine to advance precision oncology theranostics.

Recent Posts

  • AI meets nuclear medicine as Sanyou Bio and Baiyunshan Xihe pursue cancer diagnostics
  • Why Brii Bio’s BRII-179 sequencing data could reshape hepatitis B combination treatment
  • Lucerno Dynamics asset deal gives Radnostix new route into nuclear medicine workflows
  • Butterfly Network enters Brazil with iQ+ and iQ3 handheld ultrasound systems
  • Endologix DETOUR2 three-year data strengthen case for percutaneous bypass in complex SFA disease
  • Why Permeasis MTD4 could reshape enzyme replacement and intracellular drug discovery
  • Oliva Therapeutics targets thyroid treatment demand with U.S.-made Amerithroid tablets
  • ITI-9001 enters Phase 1 as Immunomic Therapeutics tests disease-modifying allergy vaccine
  • Visby Medical’s FDA-cleared at-home PCR could reshape flu and COVID-19 testing
  • Is Vilo Signal OS truly different from Oura Advisor and WHOOP’s proactive AI?
  • Evidation GLP-1 study reveals major growth runway but exposes widening access gaps
  • Why the Nona Biosciences and Lonza alliance matters for brain-penetrant biologics
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes